Therefore, it was clear that genistein can positively regulate miR-1275 to suppress the EMT and stemness of HCC cells by inhibiting the EIF5A2/PI3K/Akt signaling pathway in vivo and vitro. The gene discussed is AKT1; the disease is hepatocellular carcinoma.